Induction of MHC-mismatched mixed chimerism via anti-CD3/CD8–based conditioning corrects B-cell autoimmunity in NOD mice. Induction of MHC-mismatched mixed.

Slides:



Advertisements
Similar presentations
Lecture 8 The Development of Lymphocytes. Core content.
Advertisements

Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
G. S / AIH 2006 Graft-versus-Host disease Physiopathology Gérard Socié, MD PhD Hospital Saint Louis Translating experimental into clinical knowledge.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Natural Killer Cells:
Heather J. Symons, Moshe Y
Receipts’ Blood Receipts’ Bone Marrow Receipt’s Spleen
Transplantation David Straus, Ph.D. Objectives
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors.
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Enhanced ILC2 expansion after depletion of NK cells during the early stage of allergic and fibrotic lung inflammation. Enhanced ILC2 expansion after depletion.
Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure by Jichun Chen, Karen Lipovsky,
by Satoshi Takeuchi, and Stephen I. Katz
Chapter 9 T-cell Development
Immunological Tolerance
Depletion of Naïve Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor.
T Cell Death and Transplantation Tolerance
Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice by Yue Si, Samantha.
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte.
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Detection of CD38+IgG1+ memory B cells adjacent to contracted GCs
In Utero Depletion Of Fetal Host Hematopoietic Stem Cells Improves Engraftment Following Neonatal Transplantation In Mice by Chris Derderian, Charmin King,
IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation by Christoph Bucher, Lisa Koch, Christine.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
by Hyung-Gyoon Kim, Kyoko Kojima, C. Scott Swindle, Claudiu V
Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B by Jau-Yi Li, Jonathan Adams, Laura M. Calvi,
Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-
Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development by Armelle Le Campion, Marie-Claude Gagnerault, Cédric.
by Anil Dangi, Lei Zhang, Xiaomin Zhang, and Xunrong Luo
Survival and Function of MiHA Epitope-Specific Host CD8 TM Cells Following Ablative Conditioning and HCT  Alwi M. Shatry, Derry C. Roopenian, Robert B.
Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients  Wei He, Jeremy J. Racine, Heather F.
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells  Christian M. Schürch,
IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis
Volume 4, Issue 2, Pages (February 2003)
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation  Jeffery J. Auletta,
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions by Suparna Dutt, Michelle B. Atallah,
FGF-2 signaling mediates expansion of HSPCs
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating.
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
Gene targeting of the therapeutic EGFP/PGK‐FANCA donor in the AAVS1 locus of HD CD34+ cells Gene targeting of the therapeutic EGFP/PGK‐FANCA donor in the.
Blimp-1 expression is enhanced in both si-tolerant T cells and CD3/CD155-ligated T cells. Blimp-1 expression is enhanced in both si-tolerant T cells and.
Distribution of splenic T cells, B cells, and NK cells in NSG hL-7xhIL-15 humanized mice. Distribution of splenic T cells, B cells, and NK cells in NSG.
Deletion of CD33 does not impair engraftment, hematopoietic repopulation, and function in NSGS mice. Deletion of CD33 does not impair engraftment, hematopoietic.
SLE: the many players involved in systemic autoimmunity and tissue destruction. SLE: the many players involved in systemic autoimmunity and tissue destruction.
Analysis of peripheral blood CD4+CD25+ T-cells after B6
NOX-deficient NOD-Ncf1m1J immune system has a reduced capacity to transfer type 1 diabetes (T1D) to immune-deficient hosts. NOX-deficient NOD-Ncf1m1J immune.
Comparison of conventional NSG and hIL-7 expressing NSG humanized mice
IRS-1 and -2 expression in four mesangial cell lines from different D-NOD (A and B) and ND-NOD (C and D) mice. IRS-1 and -2 expression in four mesangial.
T1D is reduced in CT-treated NOD mice.
Phenotypic characterization of splenic and islet-infiltrating B-cells in 12-week-old NOD female mice. Phenotypic characterization of splenic and islet-infiltrating.
GLP-1 and gastrin combination therapy induces immunoregulatory cell activity in NOD mice. GLP-1 and gastrin combination therapy induces immunoregulatory.
Mechanism of action of the novel immunomodulatory regimen tested in islet transplantation in NOD mice. Mechanism of action of the novel immunomodulatory.
Flow cytometric analysis of apoptotic cells.
Major hematopoietic cell populations in NOD mice are not affected by c-Rel deficiency. Major hematopoietic cell populations in NOD mice are not affected.
Transgenic c-Maf mediates upregulation of type 2 cytokines in NOD CD4, but not CD8, cells. Transgenic c-Maf mediates upregulation of type 2 cytokines in.
Induction of MHC-mismatched mixed chimerism depletes mature but not immature BM B cells by 60 days after HCT. Control and mixed chimeric NOD mice were.
Induction of MHC-mismatched mixed chimerism depletes plasma and preplasma cells in NOD mice. Induction of MHC-mismatched mixed chimerism depletes plasma.
Progressive IGF-1 liver expression, β-cell hyperplasia, and defective insulin secretion with aging in inducible liver-specific insulin receptor knockout.
Fig. 5 Impaired colitis induction by LRH-1–deficient CD4+T cells.
Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.
Morton J Cowan, Hans-Peter Kiem  Molecular Therapy 
The selective depletion of DTR-expressing FAP+/CD45+ and FAP+/CD45− tumoral cells from bone marrow chimeric mice by the administration of DTX. A, sketch.
ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells, and NK cells. ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells,
5FU-induced specific activation of CD8+ T cells.
Plasma concentration of metabolite M1 (left panel), glucose infusion rate (GIR) to maintain euglycemia (middle panel), and blood glucose concentration.
Presentation transcript:

Induction of MHC-mismatched mixed chimerism via anti-CD3/CD8–based conditioning corrects B-cell autoimmunity in NOD mice. Induction of MHC-mismatched mixed chimerism via anti-CD3/CD8–based conditioning corrects B-cell autoimmunity in NOD mice. NOD mice begin with intrinsic B-cell defects (upper panel, left) that give rise to expanded mature autoreactive B cells (lower panel, left). Early after HCT and before donor stem cell engraftment in anti-CD3/CD8–conditioned NOD recipients, the infused donor CD8+ T cells kill the pre-existing host-type autoreactive and nonautoreactive B cells in the lympho-hematopoietic tissues such as spleen (upper panel, right). Late after HCT, when de novo–developed B cells start entering the lymphoid tissues, the donor B cells outcompete host-type B cells for vital survival factors and induce host-type B-cell apoptosis (lower panel, right). This leads to a preferential depletion of host-type autoreactive B cells, since autoreactive B cells are more susceptible than nonautoreactive B cells. Jeremy J. Racine et al. Diabetes 2014;63:2051-2062 ©2014 by American Diabetes Association